Evidence map›Paper›PMID 29453419›Full record

Trial reportEuropean journal of human genetics : EJHG2018

A randomized controlled study of a consent intervention for participating in an NIH genome sequencing study.

Erin Turbitt, Paola P Chrysostomou, Holly L Peay, Alexis R Heidlebaugh, Lawrence M Nelson, Barbara B Biesecker

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of human genetics : EJHG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05159011 (Access to Genetic Information Leveraging Innovative Technology), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05159011 nawithdrawnnot on this mapstarted 2023, after this paper: background citation

Access to Genetic Information Leveraging Innovative Technology

TypeinterventionalSponsorRTI InternationalRan2023 to 2025Enrolled0ConditionsGenetic TestingArmsAGILITY (Access to Genetic Information Leveraging Innovative TechnologY)
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Trial
  3. Review
  4. Informed Consent in the Genomics Era.Cold Spring Harbor perspectives in medicine · 2020
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Erin TurbittSocial and Behavioral Research Branch, National Human Genome Research Institute, National Institutes Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-6650-9702
Paola P ChrysostomouReproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes Health, Bethesda, MD, USA.
Holly L PeayRTI International, Chapel Hill, NC, USA.
Alexis R HeidlebaughSocial and Behavioral Research Branch, National Human Genome Research Institute, National Institutes Health, Bethesda, MD, USA.
Lawrence M NelsonReproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes Health, Bethesda, MD, USA.
Barbara B BieseckerSocial and Behavioral Research Branch, National Human Genome Research Institute, National Institutes Health, Bethesda, MD, USA. bbiesecker@rti.org.

Funding

Interventions in Genetic CounselingZIAHG200317 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BIESECKER, BARBARA BOWLES · 2009 to 2018
$7.6M
6 · The paper itself

Abstract

To make an informed choice to participate in a genome sequencing study that may yield primary and secondary findings, one understands relevant information in the context of personal values. Consent forms to enroll in a sequencing study can be long and complex. The efficacy of the professional encounter to consider the information contained in the consent form and make an informed choice is unknown. Women diagnosed with primary ovarian insufficiency and eligible for a sequencing study were randomized to participate in one of two encounters with a genetic counselor: a consent intervention using a lower literacy, less dense form or a standard consent encounter. Data were complete for 188 of 225 participants. The average time was 32 min for the intervention and 34 min for the standard, with the intervention encounter generating more questions from participants. At six weeks following consent, no differences were found between the two groups in primary outcomes: 'sequencing benefits' knowledge (d  =  0.12, 95%CI: -0.03,0.27), 'sequencing limitations' knowledge (d  =  0.04, 95%CI: -0.13,0.21), expected personal benefits (d  =  -0.01, 95%CI: -0.26,0.23), and decisional conflict (d =  0.04, 95%CI: -0.14,0.21). Although intentions to learn secondary variants were high, only 60% (113) of participants made an informed choice as defined by the multi-dimensional model of informed choice. We found that a modified consent intervention was as effective as a standard encounter and led to more interaction. Our data suggest that making decisions to receive secondary findings may be particularly challenging and in need of further investigation to achieve informed choice.

Indexed as

AdolescentAdultDecision MakingFemaleGenetic CounselingGenome, HumanHumansInformed ConsentPatient ParticipationPrimary Ovarian InsufficiencyWhole Genome SequencingYoung Adult

Identifiers

PMID29453419
PMCPMC5945708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.